Pentoxifylline is not a promising treatment for multiple sclerosis in progression phase.
Myers LW, Ellison GW, Merrill JE, El Hajjar A, St Pierre B, Hijazin M, Leake BD, Bentson JR, Nuwer MR, Tourtellotte WW, Davis P, Granger D, Fahey JL.
Myers LW, et al. Among authors: fahey jl.
Neurology. 1998 Nov;51(5):1483-6. doi: 10.1212/wnl.51.5.1483.
Neurology. 1998.
PMID: 9818891
Clinical Trial.